Patents by Inventor Frank Puglisi

Frank Puglisi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for maintaining the health of a diabetic patient by preventing the occurrence of diabetic ketoacidosis
    Patent number: 11808708
    Abstract: A method for maintaining the health of a diabetic patient by preventing onset of diabetic ketoacidosis in said patient, the method comprising: prescribing an SGLT2 inhibitor for administration to a patient in need thereof; providing at least one test strip for identifying the presence of ?-hydroxybutyrate in the patient's urine; and upon indication of the presence of ?-hydroxybutyrate in the patient's urine, discontinuing the administration of the SGLT2 inhibitor. Also disclosed is a kit useful in the monitoring of risk of onset of diabetic ketoacidosis in patients taking an SGLT2 inhibitor, the kit comprising: the SGLT2 inhibitor and at least one test strip to identify the presence of ?-hydroxybutyrate in the patient's urine, wherein the at least one test strip undergoes a change in color upon detection of ?-hydroxybutyrate in the patient's urine.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: November 7, 2023
    Assignee: F.A.T. STATS LLC
    Inventors: Tom Meitz, Frank Puglisi
  • METHOD FOR MAINTAINING THE HEALTH OF A DIABETIC PATIENT BY PREVENTING THE OCCURRENCE OF DIABETIC KETOACIDOSIS
    Publication number: 20220050057
    Abstract: A method for maintaining the health of a diabetic patient by preventing onset of diabetic ketoacidosis in said patient, the method comprising: prescribing an SGLT2 inhibitor for administration to a patient in need thereof; providing at least one test strip for identifying the presence of ?-hydroxybutyrate in the patient's urine; and upon indication of the presence of ?-hydroxybutyrate in the patient's urine, discontinuing the administration of the SGLT2 inhibitor. Also disclosed is a kit useful in the monitoring of risk of onset of diabetic ketoacidosis in patients taking an SGLT2 inhibitor, the kit comprising: the SGLT2 inhibitor and at least one test strip to identify the presence of ?-hydroxybutyrate in the patient's urine, wherein the at least one test strip undergoes a change in color upon detection of ?-hydroxybutyrate in the patient's urine.
    Type: Application
    Filed: August 6, 2021
    Publication date: February 17, 2022
    Inventors: Tom Meitz, Frank Puglisi
  • METHODS AND COMPOSITIONS FOR DETECTING BETA-HYDROXYBUTYRATE IN BIOLOGICAL FLUIDS
    Publication number: 20210147900
    Abstract: Compositions and methods for detecting ?-hydroxybutyrate in a biological fluid from a subject in need thereof are disclosed. Also disclosed are compositions and methods of reducing an optical change in a composition for detecting the ?-hydroxybutyrate during storage before the composition is exposed to the ?-hydroxybutyrate.
    Type: Application
    Filed: November 18, 2020
    Publication date: May 20, 2021
    Inventors: Tom Meitz, Frank Puglisi, Joseph Rokowski